<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        35-498-12
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2012
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        CEFOVEX 500MG TABLET
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        CEFUROXIME AXETIL
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        500
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        49.3
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="OMAN PHARMACEUTICAL PRODUCTS" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            OMAN PHARMACEUTICAL PRODUCTS
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 354]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            OMAN PHARMACEUTICAL PRODUCTS
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J01DC02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Cefovex is an antibiotic used in adults and children. It works by killing bacteria that cause infections. It belongs to a group of medicines called cephalosporins.Tablets 250 mg and 500 mg (called &lsquo;Cefovex&rsquo; in this leaflet) are cephalosporin antibiotics. The tablets contain a medicine called Cefuroxime (present as<br />cefuroxime axetil).<br />Cefovex is used to treat infections of:<br />&bull; The throat<br />&bull; Sinus<br />&bull; middle ear<br />&bull; The lungs or chest<br />&bull; the urinary tract<br />&bull; The skin and soft tissues.</p><p><br />Cefovex can also be used:<br />&bull; To treat Lyme disease (an infection spread by parasites called&nbsp;ticks).<br />Your doctor may test the type of bacteria causing your infection and monitor whether the bacteria are sensitive to Cefovex during your treatment.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not take Cefovex if you:<br />&bull; are allergic (hypersensitive) to cefuroxime, cefuroxime axetil, cephalosporin antibiotics or any of the other ingredients of Cefovex (listed in section 6)<br />&bull; has ever had an allergic (hypersensitive) reaction to any other type of betalactum antibiotic (penicillins, monobactams and carbapenems). If any of the above apply. If you are not sure, talk to your doctor or pharmacist before taking Cefovex.</p><p><br />WARNINGS AND PRECAUTIONS<br />Talk to your doctor or pharmacist before taking Cefovex Tablets</p><p>Children<br />Cefovex Tablets is not recommended for children aged less than 3 months, as the safety and effectiveness are not known in this age group.<br />You must look out for certain symptoms, such as allergic reactions, fungal infections (such as candida) and severe diarrhoea (pseudomembranous colitis) while you are taking Cefovex Tablets. This will reduce the risk of any problems. See &lsquo;Conditions you need to look out for&rsquo; in Section 4.</p><p><br />If you need a blood test<br />Cefovex can affect the results of a test for blood sugar levels, or a blood screen called the Coombs test.</p><p>If you need a blood test:<br />Tell the person taking the sample that you are taking Cefovex.</p><p><br />Taking other medicines<br />Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines.</p><p>Medicines used to reduce the amount of acid in your stomach (e.g. antacids used to treat heartburn) can affect how Cefovex works.</p><p>&bull; Probenecid<br />&bull; Oral anticoagulants<br />Tell your doctor or pharmacist if you are taking any medicine like this.</p><p>Contraceptive pills<br />Cefovex may reduce the effectiveness of the contraceptive pill. If you are taking the contraceptive pill while you are being treated with Cefovex you also need to use a barrier method of contraception (such as condoms). Ask your doctor for advice.</p><p><br />Pregnancy and breast-feeding<br />Ask your doctor or pharmacist for advice before taking any medicine if you think you might be or if you are pregnant or if you<br />are breast-feeding.</p><p><br />Driving and using machines<br />Cefovex may cause dizziness and have other side effects that make you less alert. If you feel affected you should not drive, operate machinery or take part in activities where you may put yourself or others at risk. Check with your doctor that Cefovex is suitable for you.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take Cefovex exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure. Take Cefovex after food. This will help to make the treatment more effective. Swallow Cefovex tablets whole with some water. Don&#39;t chew, crush or split the tablets &mdash; this may make the treatment less effective.</p><p>The recommended dose<br />Adults:<br />The recommended dose of Cefovex is 250 mg to 500 mg twice daily depending on the severity and type of infection.<br />Children:<br />the recommended dose of Cefovex is 10 mg/kg (to a maximum of 125 mg) to 15 mg/kg (to a maximum of 250 mg) twice daily depending on:<br />&bull; The severity and type of infection</p><p>Cefovex is not recommended for children aged under 3 months, as the safety and effectiveness are not known in this age group.<br />Depending on the illness or how you or your child responds to treatment, the initial dose may be changed or more than one course of treatment may be needed.</p><p>Patients with kidney problems<br />If you have a kidney problem, your doctor may change your dose.<br />&bull; Talk to your doctor if this applies to you</p><p>If you take more Cefovex than you should<br />If you take too much Cefovex you may have neurological disorders, in particular you may be more likely to have fits (seizures). Don&#39;t delay. Contact your doctor or your nearest hospital emergency department immediately. If possible, show them the Cefovex pack.</p><p>If you forget to take Cefovex<br />Do not take a double dose to make up for a forgotten dose. Just take your next dose at the usual time</p><p>If you stop taking Cefovex<br />Don&rsquo;t stop Cefovex without advice.<br />It is important that you take the full course of Cefovex. Don&rsquo;t stop unless your doctor advises you to &ndash; even if you are feeling better. If you don&#39;t complete the full course of treatment, the infection may come back.<br />If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>A small number of people taking Cefovex get an allergic reaction or potentially serious skin reaction. Symptoms of these reactions include:<br />&bull; Severe allergic reaction. Signs include raised and itchy rash, swelling, sometimes of the face or mouth causing difficulty in breathing.<br />&bull; Skin rash, which may blister, and looks like small targets (central dark spot surrounded by a paler area, with a dark ring around the edge).<br />&bull; a widespread rash with blisters and peeling skin. (These may be signs of Stevens-Johnson syndrome or toxic epidermal necrolysis).</p><p>Other conditions you need to look out for while taking Cefovex include:<br />&bull; Fungal infections. Medicines like Cefovex can cause an overgrowth of yeast (Candida) in the body which can lead to fungal infections (such as thrush). This side effect is more likely if you take Cefovex for a long time.<br />&bull; Severe diarrhoea (Pseudomembranous colitis). Medicines like Cefovex can cause inflammation of the colon (large intestine), causing severe diarrhoea, usually with blood and mucus, stomach pain, fever. Jarisch-Herxheimer reaction. Some patients may get a high temperature (fever), chills, headache, muscle pain and skin rash<br />while being treated with Cefovex for Lyme disease. This is known as the Jarisch-Herxheimer reaction. Symptoms usually last a few hours or up to one day.</p><p>Contact a doctor or nurse immediately if you get any of these symptoms.</p><p>Common (affects less than 1 in 10 people)<br />&bull; Fungal Infections<br />&bull; Headache<br />&bull; Dizziness<br />&bull; feeling sick (nausea)<br />&bull; diarrhoea<br />&bull; stomach pain</p><p>Common side effects that may show up in blood tests:<br />&bull; an increase in a type of white blood cell (eosinophilia)<br />&bull; an increase in liver enzymes.<br />Uncommon (affects less than 1 in 100 people)<br />&bull; skin rashes<br />&bull; being Sick</p><p>Uncommon side effects that may show up in blood tests.<br />&bull; a decrease in the number of blood platelets (cells that help blood to clot)<br />&bull; a decrease in the number of white blood cells<br />&bull; positive Coomb&rsquo;s test.</p><p>Other side effects<br />Other side effects have occurred in a very small number of people, but their exact frequency is unknown:<br />&bull; severe diarrhoea (pseudomembranous colitis)<br />&bull; allergic reactions<br />&bull; skin reactions (including severe)<br />&bull; high temperature (fever)<br />&bull; yellowing of the whites of the eyes or skin<br />&bull; Inflammation of the liver (hepatitis).</p><p>Side effects that may show up in blood tests:<br />&bull; red blood cells destroyed too quickly (haemolytic anaemia).</p><p>Reporting of side effects.<br />If you get any side effect, talk to your doctor or pharmacist. This including any possible side effects not listed in this leaflet. You can also report side effects directly.<br /><br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of the reach and sight of children.<br />&bull; Do not use Cefovex after the expiry date which is stated on the carton. The expiry date refers to the last day of that month.<br />&bull; Store below 30&deg;C.<br />&bull; Do not use Cefovex if the tablets are chipped or there are other visible signs of deterioration.<br />&bull; Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <ul><li>The active substance in each tablet is&nbsp; 500 mg cefuroxime (present as Cefuroxime axetil).</li><li>The other ingredients are microcrystalline Cellulose, pregelatinised starch, croscarmellose sodium, sodium lauryl sulphate, tabcoat TC (White), methylene chloride and isopropyl alcohol.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Cefovex Tablets 500 mg are white to off-white, capsule-shaped biconvex, coated tablets with ‘CA’ engraved on one side and plain on other side. They are packaged in aluminum foil blister packs, enclosed in a carton, which contains box of 2 strips; each strip contains 5 tablets and box of 20 strips; each strip contains 5 tablets.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorization Holder and Manufacturer</strong></p><p>Oman Pharmaceutical Product Co., LLC<br />Plot No 101, Raysut Industrial Estate,<br />Salalah, Sultanate of Oman</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                October 2021


            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">سيفوفوكس هو مضاد حيوي يستخدم في البالغين والأطفال. وهو يعمل عن طريق قتل البكتيريا المسببة للالتهابات. ينتمي إلى مجموعة من الأدوية تسمى السيفالوسبورينات.</p><p dir="RTL">يستخدم سيفوفوكس &nbsp;لعلاج التهابات:</p><ul><li dir="RTL">الحنجرة</li><li dir="RTL">الجيوب الانفية</li><li dir="RTL">الأذن الوسطى</li><li dir="RTL">الرئتين أو الصدر</li><li dir="RTL">المسالك البولية</li><li dir="RTL">الجلد والأنسجة الرخوة.</li></ul><p dir="RTL">يمكن استخدام سيفوفوكس &nbsp;أيضًا &nbsp;:</p><ul><li dir="RTL">لعلاج مرض لايم (عدوى تنتشر عن طريق الطفيليات تسمى القراد).</li></ul><p dir="RTL">طبيبك قد يجري اختبار لمعرفة نوع البكتيريا المسببة للعدوى ومراقبة ما إذا كانت البكتيريا حساسة لل سيفوفوكس أثناء علاجك.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">لا تأخذ سيفوفوكس إذا:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لديك حساسية (فرط الحساسية) لسيفوروكسيم، سيفوروكسيم أكسيتيل والمضادات الحيوية السيفالوسبورين أو أي من المكونات الأخرى للسيفوفوكس (المدرجة في القسم 6)</p><ul><li dir="RTL">أذا كأن لديك سابقا رد فعل حساسية (فرط الحساسية) لأي من مضادات البيتالاكتام الحيوية( البنسلين ، المونوباكتامز و كاربابينمز).</li></ul><p dir="RTL">إذا كان أي من أعلاه ينطبق عليك. إذا كنت غير متأكد، تحدث مع طبيبك أو الصيدلي قبل تناول سيفوفوكس.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>التحذيرات والإحتياطات</strong></p><p dir="RTL">تحدث إلى طبيبك أو الصيدلي قبل تناول أقراص سيفوفوكس</p><p dir="RTL"><strong>الأطفال</strong></p><p dir="RTL">أقراص سيفوفوكس لا ينصح بها للأطفال الذين تقل أعمارهم عن 3 أشهر ، حيث أن السلامة والفعالية غير معروفة في هذه الفئة العمرية.</p><p dir="RTL">يجب أن تبحث عن بعض الأعراض ، مثل الحساسية ، والالتهابات الفطرية (مثل المبيضات) والإسهال الحاد (التهاب القولون الغشائي الكاذب) أثناء تناولك أقراص سيفوفوكس ، وهذا سوف يقلل من خطر أي مشاكل. راجع &quot;الشروط التي تحتاج إلى البحث عنها&quot; في القسم 4.</p><p dir="RTL">إذا كنت بحاجة إلى فحص الدم</p><p dir="RTL">يمكن أن يؤثر سيفوفوكس على نتائج اختبار مستويات السكر في الدم ، أو تَحَرِّي الدم يسمى اختبار Coombs. إذا كنت بحاجة إلى فحص دم:</p><p dir="RTL">أخبر الشخص الذي أخذ العينة أنك تتناول سيفوفوكس.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>تناول أدوية أخرى</strong></p><p dir="RTL">يرجى إخبار الطبيب أو الصيدلي إذا كنت تتناول أو تناولت مؤخرا أي أدوية أخرى.</p><p dir="RTL">الأدوية المستخدمة لتقليل كمية الحمض في المعدة (مثل مضادات الحموضة المستخدمة لعلاج حرقة) يمكن أن تؤثر على كيفية عمل سيفوفوكس</p><ul><li dir="RTL">بالبروبنيسيد</li><li dir="RTL">مضادات التخثر الفموية</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>أخبر طبيبك أو الصيدلي</strong> إذا كنت تتناول أي دواء كهذا.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>حبوب منع الحمل</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">سيفوفوكس قد يقلل من فعالية حبوب منع الحمل. إذا كنت تتناولين حبوب منع الحمل أثناء علاجك بـسيفوفوكس ، فأنت بحاجة أيضًا إلى استخدام طريقة اخرى لمنع الحمل (مثل الواقي الذكري). إسألي طبيبك للحصول على المشورة.</p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية</strong></p><p dir="RTL">إسألي طبيبك أو الصيدلي للحصول على المشورة قبل تناول أي دواء إذا كنت تعتقدين أو إذا كنت حاملا أو إذا كنت مرضعة طبيعيا.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>القيادة واستخدام الآليات</strong></p><p dir="RTL">سيفوفوكس قد يسبب دوخة وله آثار جانبية أخرى تجعلك أقل يقظة. إذا شعرت بها&nbsp; يجب أن لا تقوم بالقيادة، وتشغيل الآلات أو تقوم بالمشاركة في الأنشطة التي قد تضع نفسك أو الآخرين للخطر.</p><p dir="RTL">تحقق مع طبيبك أن سيفوفيكس مناسب لك</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">دائما تناول سيفوفوكس تماما كما قال لك طبيبك . يجب عليك التحقق مع طبيبك أو الصيدلي إذا كنت غير متأكد.</p><p dir="RTL"><strong>تناول سيفوفوكس بعد الطعام</strong>. هذا سوف يساعد على جعل العلاج أكثر فعالية.</p><p dir="RTL">ابتلاع أقراص سيفوفوكس كاملة مع بعض الماء.</p><p dir="RTL"><strong>لا تمضغ أو تسحق أو تقص الأقراص</strong> - وهذا قد يجعل العلاج أقل فعالية.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الجرعة الموصى بها</strong></p><p dir="RTL"><strong>البالغون</strong></p><p dir="RTL">الجرعة الموصى بها من سيفوفوكس هي 250 ملجم إلى 500 ملجم مرتين يوميًا اعتمادًا على شدة العدوى ونوعها.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الأطفال</strong></p><p dir="RTL">الجرعة الموصى بها من سيفوفوكس هي 10 ملجم / كجم (بحد أقصى 125 ملجم) إلى 15 ملجم / كجم (بحد أقصى 250 ملجم) مرتين يوميًا اعتمادًا على :</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; شدة العدوى ونوعها</p><p dir="RTL"><strong>لا ينصح باستخدام سيفوفوكس للأطفال الذين تقل أعمارهم عن 3 أشهر</strong> ، حيث أن السلامة والفعالية غير معروفة في هذه الفئة العمرية.</p><p dir="RTL">اعتمادًا على المرض أو كيفية استجابتك انت أو طفلك للعلاج ، قد يتم تغيير الجرعة الأولية أو قد تكون هناك حاجة إلى أكثر من دورة علاجية واحدة.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>المرضى الذين يعانون من مشاكل في الكلى</strong></p><p dir="RTL">إذا كنت تعاني من مشكلة في الكلى ، فقد يغير طبيبك الجرعة.</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>تحدث إلى طبيبك</strong> إذا كان هذا ينطبق عليك</p><p dir="RTL"><strong>إذا كنت تتناول سيفوفوكس أكثر مما يجب</strong></p><p dir="RTL">إذا كنت تتناول الكثير من سيفوفوكس ، فقد تكون لديك اضطرابات عصبية ، وعلى وجه الخصوص قد تكون<strong> أكثر عرضة للنوبات</strong> (الصرع).</p><p dir="RTL"><strong>لا تؤجل. اتصل بطبيبك أو أقرب قسم للطوارئ في المستشفى على الفور</strong>. إذا كان ذلك ممكنًا ، أظهر لهم عبوة سيفوفوكس.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا نسيت أن تتناول سيفوفوكس</strong></p><p dir="RTL"><strong>لا تأخذ جرعة مضاعفة لتعويض الجرعة المنسية</strong>. فقط تناول &nbsp;الجرعة التالية في الوقت المعتاد.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>إذا توقفت عن تناول سيفوفوكس</strong></p><p dir="RTL"><strong>لا تتوقف عن سيفوفيكس بدون نصيحة طبية.</strong></p><p dir="RTL"><strong>من المهم أن تأخذ دورة كاملة من سيفوفوكس</strong>. لا تتوقف إلا إذا نصحك طبيبك بذلك - حتى لو كنت تشعر بتحسن. إذا لم تكمل الدورة الكاملة للعلاج ، فقد تعود العدوى.</p><p dir="RTL">إذا كان لديك أي أسئلة أخرى حول استخدام هذا الدواء ، اسأل طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يعاني عدد صغير من الأشخاص الذين يتناولون سيفوفوكس من رد فعل تحسسي أو رد فعل جلدي خطير. أعراض هذه التفاعلات تشمل:</p><p dir="RTL"><strong>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>الحساسية الشديدة</strong>. تتضمن العلامات <strong>طفحًا مرتفعًا وحكة ، وتورمًا</strong> ، وأحيانًا في الوجه أو الفم مما يسبب <strong>صعوبة في التنفس.</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>طفح جلدي</strong> ، مع <strong>بثور</strong> ، وتبدو وكأنها <strong>أهداف صغيرة </strong>(بقعة مظلمة مركزية محاطة بمنطقة شاحبة ، مع حلقة داكنة حول الحافة).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>طفح على نطاق واسع</strong> مع ظهور <strong>بثور</strong> <strong>وتقشير الجلد</strong>. (قد تكون هذه علامات على متلازمة ستيفنز جونسون أو تنخر البشرة السمي).</p><p dir="RTL">تشمل الحالات الأخرى التي يجب عليك البحث عنها أثناء تناول سيفوفوكس:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>الالتهابات الفطرية</strong>. يمكن لأدوية مثل سيفوفوكس أن تسبب فرط نمو الخميرة (المبيضات) في الجسم مما قد يؤدي إلى حدوث عدوى فطرية (مثل مرض القلاع). هذا التأثير الجانبي هو الأرجح إذا كنت تأخذ سيفوفوكس لفترة طويلة.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;<strong>الإسهال الحاد</strong> (التهاب القولون الغشائي الكاذب). يمكن لأدوية مثل سيفوفوكس أن تسبب التهابًا في القولون (الأمعاء الغليظة) ، مما يسبب الإسهال الحاد ، وعادة ما يكون مع الدم والمخاط وآلام في المعدة والحمى.</p><p dir="RTL"><strong>رد فعل ياريش هيرشيمر</strong>. قد يصاب بعض المرضى بارتفاع في درجة الحرارة (حمى) ، قشعريرة ، صداع ، ألم عضلي وطفح جلدي أثناء علاجهم بـ سيفوفوكس لمرض لايم. هذا هو المعروف باسم رد الفعل ياريش هيرشيمر. تستمر الأعراض عادة بضع ساعات أو حتى يوم واحد.</p><p dir="RTL"><strong>اتصل بالطبيب أو الممرضة على الفور إذا ظهرت لك أي من هذه الأعراض.</strong></p><p dir="RTL"><strong>الشائعة</strong> (تؤثر في أقل من 1 من كل 10 شخص)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الالتهابات الفطرية</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صداع الراس</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;دوخة</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالغثيان (الغثيان)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إسهال</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; آلام في المعدة</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الآثار الجانبية الشائعة التي قد تظهر في اختبارات الدم:</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة في نوع من خلايا الدم البيضاء (الحمضات)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة في أنزيمات الكبد.</p><p dir="RTL"><strong>الغير شائعة</strong> (تؤثر أقل من 1 في 100 شخص)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الغثيان (القيء)</p><p dir="RTL">الآثار الجانبية غير المألوفة التي قد تظهر في اختبارات الدم.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض عدد الصفائح الدموية (الخلايا التي تساعد على تجلط الدم)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض في عدد خلايا الدم البيضاء</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اختبار كومب الإيجابي.</p><p dir="RTL"><strong>آثار جانبية أخرى</strong></p><p dir="RTL">حدثت آثار جانبية أخرى في عدد صغير جدًا من الأشخاص ، لكن ترددها الدقيق غير معروف:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإسهال الحاد (التهاب القولون الغشائي الكاذب)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الحساسية</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ردود فعل الجلد (بما في ذلك شديدة)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع درجة الحرارة (الحمى)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اصفرار بياض العينين أو الجلد</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;التهاب الكبد (التهاب الكبد).</p><p dir="RTL">الآثار الجانبية التي قد تظهر في اختبارات الدم:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تدمير خلايا الدم الحمراء بسرعة كبيرة (فقر الدم الانحلالي).</p><p dir="RTL"><strong>الإبلاغ عن الآثار الجانبية</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحفظ بعيدا عن متناول وبصر الأطفال.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تستخدم سيفوفوكس بعد تاريخ انتهاء الصلاحية التي المنصوص عليه بالعبوة. تاريخ انتهاء يشير إلى اليوم الأخير من ذلك الشهر.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحفظ&nbsp; في درجة حرارة أو أقل من 30&nbsp; درجة مئوية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تستخدم سيفوفوكس إذا كانت الأقراص متكسرة&nbsp; أو أذا كانت هناك علامات واضحة أخرى على تلف الاقراص.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يجب أن لا يتم التخلص من الأدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي كيفية التخلص من الأدوية التي لم تعد مطلوبة. وسوف تساعد هذه التدابير على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&nbsp;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المادة الفعالة في كل قرص 250 ملجم أو هو 500 ملجم هي سيفوروكسيم (يقدم كسيفوروكسيم اكسيتيل).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المكونات الأخرى هي السليلوز الجريزوفولفين، النشا البريجلاتينايزد ، كروسكارميلوز الصوديوم، كبريتات الصوديوم لوريل، تابكوت TC (أبيض)، وكلوريد الميثيلين وايزوبروبيل الكحول.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&nbsp;</p><p dir="RTL" style="text-align:right">أقراص سيفوفوكس 500 ملجم هي أقراص بيضاء،&nbsp; بشكل كبسولة مغلفة ثنائية التحدب محفور &#39;CA&#39; على جانب واحد وأملس على الجانب الآخر. معبأه في شريط من الألومنيوم، مغلقة في الكرتون الذي يحتوي على عدد 2 شرائط، كل شريط يحتوي على 5 أقراص</p><p style="text-align:right">كرتون يحتوي على عدد 20 شريط؛ كل شريط يحتوي على 5 أقراص.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">الشركة العمانية لمستحضرات الصيدلة ش.م.م</p><p dir="RTL">قطعة رقم 101 ، منطقة ريسوت الصناعية ،</p><p dir="RTL">صلالة ، سلطنة عمان</p><p dir="RTL">البريد الإلكتروني: reg@omanpharma.com و pv@omanpharma.com</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت المراجعة الاخيرة للنشرة بتاريخ: اكتوبر 2021.
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                1.	NAME OF THE MEDICINAL PRODUCT
Cefovex-250mg & Cefovex-500mg tablets


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2.	QUALITATIVE AND QUANTITATIVE COMPOSITION
Cefovex-250: Each film coated tablet contains cefuroxime axetil equivalent to cefuroxime 250 mg.
Cefovex-500: Each film coated tablet contains cefuroxime axetil equivalent to cefuroxime 500 mg.
Excipients are Microcrystalline Cellulose, Pregelatinised Starch, Croscarmellose Sodium, Sodium Lauryl Sulphate, Tabcoat TC (White), Dichloromethane and Isopropyl Alcohol.
Tabcoat TC contains Hydroxy Propyl Methyl Cellulose, Polyethylene Glycol, Talc & Titanium Dioxide.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3.	PHARMACEUTICAL FORM
White to off white, capsule shaped, biconcex, coated tablets with “CA” engraved on one side and plain on the other side.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">4.&nbsp; &nbsp; CLINICAL PARTICULARS</p><p style="text-align:justify"><strong>4.1&nbsp;</strong><strong>Therapeutic indications</strong></p><p style="text-align:justify"><strong>&nbsp;</strong>Cefuroxime axetil is indicated for the treatment of mild to moderately severe infections caused by micro-organisms susceptible to cefuroxime, such as:</p><p style="text-align:justify">-&nbsp; upper respiratory tract infections: acute otitis media, sinusitis, tonsillitis and pharyngitis</p><p style="text-align:justify">-&nbsp; acute bronchitis, acute exacerbations of chronic bronchitis</p><p style="text-align:justify">-&nbsp; lower uncomplicated urinary tract infections: cystitis</p><p style="text-align:justify">-&nbsp; skin and soft tissue infections: furunculosis, pyoderma and impetigo</p><p style="text-align:justify">-&nbsp;&nbsp; treatment of early stage Lyme disease (stadium I) and subsequent prevention of late complications in adults and children above 12 years of age.</p><p style="text-align:justify">Consideration should be given to official guidance on the appropriate use of antibacterial agents.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify"><u>Posology</u></p><p style="text-align:justify"><em>Table 1. Adults and children (&ge;40 kg)</em></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p style="text-align:justify"><strong>Indication</strong></p></td><td style="vertical-align:top"><p style="text-align:justify"><strong>Dosage</strong></p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify">Acute tonsillitis and pharyngitis, acute bacterial sinusitis</p></td><td style="vertical-align:top"><p style="text-align:justify">250 mg twice daily</p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify">Acute otitis media</p></td><td style="vertical-align:top"><p style="text-align:justify">500 mg twice daily</p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify"><em>&nbsp;</em></p><p style="text-align:justify">Acute exacerbations of chronic bronchitis</p></td><td style="vertical-align:top"><p style="text-align:justify"><em>&nbsp;</em></p><p style="text-align:justify">500 mg twice daily</p></td></tr></tbody></table><p style="text-align:justify">&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p style="text-align:justify">Cystitis</p></td><td style="vertical-align:top"><p style="text-align:justify">250 mg twice daily</p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify">Pyelonephritis</p></td><td style="vertical-align:top"><p style="text-align:justify">250 mg twice daily</p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify">Uncomplicated skin and soft tissue infections</p></td><td style="vertical-align:top"><p style="text-align:justify">250 mg twice daily</p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify"><em>&nbsp;</em></p><p style="text-align:justify">Lyme disease</p></td><td style="vertical-align:top"><p style="text-align:justify">500 mg twice daily for 14 days (range of 10 to 21 days)</p></td></tr></tbody></table><p style="text-align:justify"><em>&nbsp;</em></p><p style="text-align:justify"><em>Table 2. Children (&lt;40 kg)</em></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p style="text-align:justify">Acute tonsillitis and pharyngitis, acute bacterial sinusitis</p></td><td style="vertical-align:top"><p style="text-align:justify">10 mg/kg twice daily to a maximum of 125 mg twice daily</p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify">Children aged two years or older with otitis media or, where appropriate, with more severe infections</p></td><td style="vertical-align:top"><p style="text-align:justify">15 mg/kg twice daily to a maximum of 250 mg twice daily</p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify">Cystitis</p></td><td style="vertical-align:top"><p style="text-align:justify">15 mg/kg twice daily to a maximum of 250 mg twice daily</p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify">Pyelonephritis</p></td><td style="vertical-align:top"><p style="text-align:justify">15 mg/kg twice daily to a maximum of 250 mg twice daily for 10 to 14 days</p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify">Uncomplicated skin and soft tissue infections</p></td><td style="vertical-align:top"><p style="text-align:justify">15 mg/kg twice daily to a maximum of 250 mg twice daily</p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify">Lyme disease</p></td><td style="vertical-align:top"><p style="text-align:justify">15 mg/kg twice daily to a maximum of 250 mg twice daily for 14 days (10 to 21 days)</p></td></tr></tbody></table><p style="text-align:justify"><em>&nbsp;</em></p><p style="text-align:justify">There is no experience of using cefuroxime in children under 3 months of age.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><em>Renal impairment</em></p><p style="text-align:justify">The safety and efficacy of cefuroxime axetil in patients with renal failure have not been established. Cefuroxime is primarily excreted by the kidneys. In patients with markedly impaired renal function it is recommended that the dosage of cefuroxime should be reduced to compensate for its slower excretion. Cefuroxime is effectively removed by dialysis.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><em>Table 5. Recommended doses for Cefuroxime in renal impairment</em></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p style="text-align:justify"><strong>Creatinine clearance</strong></p></td><td style="vertical-align:top"><p style="text-align:justify"><strong>T<sub>1/2</sub> (hrs)</strong></p></td><td style="vertical-align:top"><p style="text-align:justify"><strong>Recommended dosage</strong></p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify">&ge;30 ml/min/1.73 m<sup>2</sup></p></td><td style="vertical-align:top"><p style="text-align:justify">1.4&ndash;2.4</p></td><td style="vertical-align:top"><p style="text-align:justify">no dose adjustment necessary (standard dose of 125 mg to 500</p><p style="text-align:justify">mg given twice daily)</p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify">10-29 ml/min/1.73 m<sup>2</sup></p></td><td style="vertical-align:top"><p style="text-align:justify">4.6</p></td><td style="vertical-align:top"><p style="text-align:justify">standard individual dose given every 24</p><p style="text-align:justify">hours</p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify">&lt;10 ml/min/1.73 m<sup>2</sup></p></td><td style="vertical-align:top"><p style="text-align:justify">16.8</p></td><td style="vertical-align:top"><p style="text-align:justify">standard individual dose given every 48</p><p style="text-align:justify">hours</p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify">During haemodialysis</p></td><td style="vertical-align:top"><p style="text-align:justify">2&ndash;4</p></td><td style="vertical-align:top"><p style="text-align:justify">a single additional standard individual dose should be given at the end of each</p><p style="text-align:justify">dialysis</p></td></tr></tbody></table><p style="text-align:justify"><em>&nbsp;</em></p><p style="text-align:justify"><em>Hepatic impairment</em></p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify">There are no data available for patients with hepatic impairment. Since cefuroxime is primarily eliminated by the kidney,</p><p style="text-align:justify">the presence of hepatic dysfunction is expected to have no effect on the pharmacokinetics of cefuroxime.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><u>Method of administration</u> Oral use</p><p style="text-align:justify">Cefovex tablets should be taken after food for optimum absorption.</p><p style="text-align:justify">Cefovex tablets should not be crushed and are therefore unsuitable for treatment of patients who cannot swallow tablets. In children cefuroxime oral suspension may be used.</p><p style="text-align:justify">Depending on the dosage, there are other presentations available.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to cefuroxime, other cephalosporins or to any of the excipients listed in section 6.1. Patients with known hypersensitivity to cephalosporin antibiotics.
History of severe hypersensitivity (e.g. anaphylactic reaction) to any other type of betalactam antibacterial agent (penicillins, monobactams and carbapenems).


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify"><u>Hypersensitivity reactions</u></p><p style="text-align:justify">Special care is indicated in patients who have experienced an allergic reaction to penicillins or other beta-lactams. As with all beta-lactam antibacterial agents, serious and occasionally fatal hypersensitivity reactions have been reported. In case of severe hypersensitivity reactions, treatment with cefuroxime must be discontinued immediately and adequate emergency measures must be initiated.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify">Before beginning treatment, it should be established whether the patient has a history of severe hypersensitivity reactions to cefuroxime, to other cephalosporins or to any other type of beta-lactam agent. Caution should be used if cefuroxime is given to patients with a history of non-severe hypersensitivity to other beta-lactam agents.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><u>Jarisch-Herxheimer reaction</u></p><p style="text-align:justify">The Jarisch-Herxheimer reaction has been seen following cefuroxime axetil treatment of Lyme disease. It results directly from the bactericidal activity of cefuroxime axetil on the causative bacteria of Lyme disease, the spirochaete <em>Borrelia burgdorferi</em>. Patients should be reassured that this is a common and usually self-limiting consequence of antibiotic treatment of Lyme disease (see section 4.8).</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><u>Overgrowth of non-susceptible microorganisms</u></p><p style="text-align:justify">As with other antibiotics, use of cefuroxime axetil may result in the overgrowth of Candida. Prolonged use may also result in the overgrowth of other non-susceptible microorganisms (e.g. enterococci and <em>Clostridium difficile</em>), which may require interruption of treatment (see section 4.8). Antibacterial agent&ndash;associated pseudomembranous colitis have been reported with nearly all antibacterial agents, including cefuroxime and may range in severity from mild to life threatening. This diagnosis should be considered in patients with diarrhoea during or subsequent to the administration of cefuroxime (see section 4.8). Discontinuation of therapy with cefuroxime and the administration of specific treatment for <em>Clostridium difficile </em>should be considered. Medicinal products that inhibit peristalsis should not be given (see section 4.8).</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><u>Interference with diagnostic tests</u></p><p style="text-align:justify">The development of a positive Coombs Test associated with the use of cefuroxime may interfere with cross matching of blood (see section 4.8).</p><p style="text-align:justify">As a false negative result may occur in the ferricyanide test, it is recommended that either the glucose oxidase or hexokinase methods are used to determine blood/plasma glucose levels in patients receiving cefuroxime axetil.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">Drugs which reduce gastric acidity may result in a lower bioavailability of cefuroxime axetil compared with that of the fasting state and tend to cancel the effect of enhanced absorption after food.</p><p style="text-align:justify">Cefuroxime axetil may affect the gut flora, leading to lower oestrogen reabsorption and reduced efficacy of combined oral contraceptives.</p><p style="text-align:justify">Cefuroxime is excreted by glomerular filtration and tubular secretion. Concomitant use of probenicid is not recommended. Concurrent administration of probenecid significantly increases the peak concentration, area under the serum concentration time curve and elimination half-life of cefuroxime.</p><p style="text-align:justify">Concomitant use with oral anticoagulants may give rise to increased INR.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify"><u>Pregnancy</u></p><p style="text-align:justify">There are limited data from the use of cefuroxime in pregnant women. Studies in animals have shown no harmful effects on pregnancy, embryonal or foetal development, parturition or postnatal development. Cefuroxime should be prescribed to pregnant women only if the benefit outweighs the risk.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><u>Breastfeeding</u></p><p style="text-align:justify">Cefuroxime is excreted in human milk in small quantities. Adverse effects at therapeutic doses are not expected, although a risk of diarrhoea and fungus infection of the mucous membranes cannot be excluded. Breastfeeding might have to be discontinued due to these effects. The possibility of sensitisation should be taken into account. Cefuroxime should only be used during breastfeeding after benefit/risk assessment by the physician in charge.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><u>Fertility</u></p><p style="text-align:justify">There are no data on the effects of cefuroxime axetil on fertility in humans. Reproductive studies in animals have shown no effects on fertility.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">No studies on the effects on the ability to drive and use machines have been performed. However, as this medicine may cause dizziness, patients should be warned to be cautious when driving or operating machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">The most common adverse reactions are <em>Candida </em>overgrowth, eosinophilia, headache, dizziness, gastrointestinal disturbances and transient rise in liver enzymes.</p><p style="text-align:justify">The frequency categories assigned to the adverse reactions below are estimates, as for most reactions suitable data (for example from placebo-controlled studies) for calculating incidence were not available. In addition the incidence of adverse reactions associated with cefuroxime axetil may vary according to the indication.</p><p style="text-align:justify">Data from large clinical studies were used to determine the frequency of very common to rare undesirable effects. The frequencies assigned to all other undesirable effects (i.e. those occurring at</p><p style="text-align:justify">&lt;1/10,000) were mainly determined using post-marketing data and refer to a reporting rate rather</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify">than true frequency. Placebo-controlled trial data were not available. Where incidences have been calculated from clinical trial data, these were based on drug-related (investigator assessed) data. Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.</p><p style="text-align:justify">Treatment related adverse reactions, all grades, are listed below by MedDRA body system organ class, frequency and grade of severity. The following convention has been utilised for the classification of frequency: very common &ge; 1/10;</p><p style="text-align:justify">common &ge; 1/100 to &lt; 1/10, uncommon &ge; 1/1,000 to &lt; 1/100; rare &ge; 1/10,000 to &lt; 1/1,000; very rare</p><p style="text-align:justify">&lt; 1/10,000 and not <em>known (cannot be estimated from the available data).</em></p><p style="text-align:justify"><em>&nbsp;</em></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p style="text-align:justify"><strong>System organ class</strong></p></td><td style="vertical-align:top"><p style="text-align:justify"><strong>Common</strong></p></td><td style="vertical-align:top"><p style="text-align:justify"><strong>Uncommon</strong></p></td><td style="vertical-align:top"><p style="text-align:justify"><strong>Not known</strong></p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify"><em>Infections and infestations</em></p></td><td style="vertical-align:top"><p style="text-align:justify"><em>Candida </em>overgrowth</p></td><td style="vertical-align:top"><p style="text-align:justify">&nbsp;</p></td><td style="vertical-align:top"><p style="text-align:justify"><em>Clostridium difficile</em></p><p style="text-align:justify">overgrowth</p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify">Blood and lymphatic system disorders</p></td><td style="vertical-align:top"><p style="text-align:justify">eosinophilia</p></td><td style="vertical-align:top"><p style="text-align:justify">positive Coomb&#39;s test, thrombocytopenia, leukopenia (sometimes</p><p style="text-align:justify">profound)</p></td><td style="vertical-align:top"><p style="text-align:justify">haemolytic anaemia</p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify">Immune system disorders</p></td><td style="vertical-align:top"><p style="text-align:justify">&nbsp;</p></td><td style="vertical-align:top"><p style="text-align:justify">&nbsp;</p></td><td style="vertical-align:top"><p style="text-align:justify">drug fever, serum sickness, anaphylaxis, Jarisch-Herxheimer</p><p style="text-align:justify">reaction</p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify">Nervous system</p><p style="text-align:justify">disorders</p></td><td style="vertical-align:top"><p style="text-align:justify">headache, dizziness</p></td><td style="vertical-align:top"><p style="text-align:justify">&nbsp;</p></td><td style="vertical-align:top"><p style="text-align:justify">&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify">Gastrointestinal</p><p style="text-align:justify">disorders</p></td><td style="vertical-align:top"><p style="text-align:justify">diarrhoea, nausea,</p><p style="text-align:justify">abdominal pain</p></td><td style="vertical-align:top"><p style="text-align:justify">vomiting</p></td><td style="vertical-align:top"><p style="text-align:justify">pseudomembranous</p><p style="text-align:justify">colitis (see section 4.4)</p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify">Hepatobiliary disorders</p></td><td style="vertical-align:top"><p style="text-align:justify">transient increases of hepatic enzyme</p><p style="text-align:justify">levels</p></td><td style="vertical-align:top"><p style="text-align:justify">&nbsp;</p></td><td style="vertical-align:top"><p style="text-align:justify">Jaundice (predominantly cholestatic), hepatitis</p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify">Skin and subcutaneous tissue disorders</p></td><td style="vertical-align:top"><p style="text-align:justify">&nbsp;</p></td><td style="vertical-align:top"><p style="text-align:justify">skin rashes</p></td><td style="vertical-align:top"><p style="text-align:justify">urticaria, pruritus, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis (exanthematic necrolysis) (<em>see Immune system</em></p><p style="text-align:justify"><em>disorders</em>), angioneurotic oedema</p></td></tr><tr><td colspan="4" style="vertical-align:top"><p style="text-align:justify"><em>Description of selected adverse reactions</em></p></td></tr><tr><td colspan="4" style="vertical-align:top"><p style="text-align:justify">Cephalosporins as a class tend to be absorbed onto the surface of red cells membranes and react with antibodies directed against the drug to produce a positive Coombs test (which can interfere with cross-matching of blood) and very rarely haemolytic anaemia.</p><p style="text-align:justify">Transient rises in serum liver enzymes have been observed which are usually reversible.</p></td></tr></tbody></table><p style="text-align:justify"><em>Paediatric population</em></p><p style="text-align:justify">The safety profile for cefuroxime axetil in children is consistent with the profile in adults.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">Overdose can lead to neurological sequelae including encephalopathy, convulsions and coma. Symptoms of overdose can occur if the dose is not reduced appropriately in patients with renal impairment (see sections 4.2 and 4.4).</p><p style="text-align:justify">Serum levels of cefuroxime can be reduced by haemodialysis and peritoneal dialysis.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">Pharmacotherapeutic&nbsp;&nbsp;&nbsp;&nbsp; group:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; antibacterials&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; for&nbsp;&nbsp;&nbsp;&nbsp; systemic&nbsp;&nbsp;&nbsp;&nbsp; use,&nbsp;&nbsp;&nbsp;&nbsp; second-generation cephalosporins, ATC-Code: J01DC02</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><u>Mechanism of action</u></p><p style="text-align:justify">Cefuroxime axetil undergoes hydrolysis by esterase enzymes to the active antibiotic, cefuroxime.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify">Cefuroxime inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs). This results in the interruption of cell wall (peptidoglycan) biosynthesis, which leads to bacterial cell lysis and death.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><u>Mechanism of resistance</u></p><p style="text-align:justify">Bacterial resistance to cefuroxime may be due to one or more of the following mechanisms:</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; hydrolysis by beta-lactamases; including (but not limited to) by extended-spectrum beta- lactamases (ESBLs) and by the chromosomally-encoded (AmpC) enzyme that may be induced or stably derepressed in certain aerobic Gram-negative bacterial species</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; reduced affinity of penicillin-binding proteins for cefuroxime</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; outer membrane impermeability, which restricts access of cefuroxime to penicillin binding proteins in gram-negative bacteria;</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; bacterial efflux pumps</p><p style="text-align:justify">Organisms that have acquired resistance to other injectable cephalosporins are expected to be resistant to cefuroxime.</p><p style="text-align:justify">Depending on the mechanism of resistance, organisms with acquired resistance to penicillins may</p><p style="text-align:justify">demonstrate reduced susceptibility or resistance to cefuroxime. <u>Cefuroxime axetil breakpoints:</u></p><p style="text-align:justify">Minimum inhibitory concentration (MIC) breakpoints established by the European Committee on Antimicrobial Susceptibility Testing (EUCAST) are as follows:</p><p style="text-align:justify">&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p style="text-align:justify"><strong>Microorganism</strong></p></td><td colspan="2" style="vertical-align:top"><p style="text-align:justify"><strong>Breakpoints (mg/L)</strong></p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify">&nbsp;</p></td><td style="vertical-align:top"><p style="text-align:justify"><u>S</u></p></td><td style="vertical-align:top"><p style="text-align:justify"><u>R</u></p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify"><em>Enterobacteriaceae </em>1, 2</p></td><td style="vertical-align:top"><p style="text-align:justify">&le;8</p></td><td style="vertical-align:top"><p style="text-align:justify">&gt;8</p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify"><em>Staphylococcus </em>spp.</p></td><td style="vertical-align:top"><p style="text-align:justify">Note<sup>3</sup></p></td><td style="vertical-align:top"><p style="text-align:justify">Note<sup>3</sup></p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify"><em>Streptococcus </em>A, B, C and G</p></td><td style="vertical-align:top"><p style="text-align:justify">Note<sup>4</sup></p></td><td style="vertical-align:top"><p style="text-align:justify">Note<sup>4</sup></p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify"><em>Streptococcus pneumoniae</em></p></td><td style="vertical-align:top"><p style="text-align:justify">&le;0.25</p></td><td style="vertical-align:top"><p style="text-align:justify">&gt;0.5</p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify"><em>Moraxella catarrhalis</em></p></td><td style="vertical-align:top"><p style="text-align:justify">&le;0.125</p></td><td style="vertical-align:top"><p style="text-align:justify">&gt;4</p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify"><em>Haemophilus influenzae</em></p></td><td style="vertical-align:top"><p style="text-align:justify">&le;0.125</p></td><td style="vertical-align:top"><p style="text-align:justify">&gt;1</p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify">Non-species&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; related breakpoints1</p></td><td style="vertical-align:top"><p style="text-align:justify">IE<sup>5</sup></p></td><td style="vertical-align:top"><p style="text-align:justify">IE<sup>5</sup></p></td></tr><tr><td colspan="3" style="vertical-align:top"><p style="text-align:justify"><strong><sup>1</sup> </strong>The cephalosporin breakpoints for <em>Enterobacteriaceae </em>will detect all clinically important resistance mechanisms (including ESBL and plasmid mediated AmpC). Some strains that produce beta-lactamases are susceptible or intermediate to 3rd or 4th generation cephalosporins with these breakpoints and should be reported as found, i.e. the presence or absence of an ESBL does not in itself influence the categorization of susceptibility. In many areas, ESBL detection and characterization is recommended or mandatory for infection control purposes.</p><p style="text-align:justify"><sup>2</sup> Uncomplicated UTI (cystitis) only (see section 4.1).</p><p style="text-align:justify"><sup>3</sup> Susceptibility of staphylococci to cephalosporins is inferred from the methicillin susceptibility except for ceftazidme and cefixime and ceftibuten, which do not have breakpoints and should not be used for staphylococcal infections.</p><p style="text-align:justify"><sup>4</sup> The beta-lactam susceptability of beta-haemolytic streptococci groups A, B, C and G is inferred from the penicillin susceptibility.</p><p style="text-align:justify"><sup>5</sup> insufficient evidence that the species in question is a good target for therapy with the drug. An MIC with a comment but without an accompanying S or R-categorization may be reported.</p></td></tr></tbody></table><p style="text-align:justify">S=susceptible, R=resistant <u>Microbiological susceptibility:</u></p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify">The prevalence of acquired resistance may vary geographically and with time for selected species and local information on resistance is desirable, particularly when treating severe infections. As necessary, expert advice should be sought when the local prevalence of resistance is such that the utility of the agent in at least some types of infections is questionable.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify">Cefuroxime is usually active against the following microorganisms <em>in vitro.</em></p><p style="text-align:justify"><em>&nbsp;</em></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p style="text-align:justify"><strong>Commonly susceptible species</strong></p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify"><u>Gram-positive aerobes:</u></p><p style="text-align:justify"><em>Staphylococcus aureus </em>(methicillin susceptible)<em>* Coagulase negative staphylococcus (methicillin susceptible) Streptococcus pyogenes</em></p><p style="text-align:justify"><em>Streptococcus agalactiae</em></p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify"><u>Gram-negative aerobes:</u> <em>Haemophilus influenzae Haemophilus parainfluenzae</em></p><p style="text-align:justify"><em>Moraxella catarrhalis</em></p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify"><u>Spirochaetes:</u></p><p style="text-align:justify"><em>Borrelia burgdorferi</em></p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify"><strong>Microorganisms for which acquired resistance may be a problem</strong></p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify"><u>Gram-positive aerobes:</u></p><p style="text-align:justify"><em>Streptococcus pneumoniae</em></p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify"><u>Gram-negative aerobes:</u> <em>Citrobacter freundii Enterobacter aerogenes Enterobacter cloacae Escherichia coli Klebsiella pneumoniae Proteus mirabilis</em></p><p style="text-align:justify"><em>Proteus </em>spp.(other than <em>P. vulgaris)</em></p><p style="text-align:justify"><em>Providencia </em>spp.</p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify"><u>Gram-positive anaerobes:</u></p><p style="text-align:justify"><em>Peptostreptococcus </em>spp.</p><p style="text-align:justify"><em>Propionibacterium </em>spp.</p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify"><u>Gram-negative anaerobes:</u></p><p style="text-align:justify"><em>Fusobacterium </em>spp.</p><p style="text-align:justify"><em>Bacteroides </em>spp.</p></td></tr></tbody></table><p style="text-align:justify">&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p style="text-align:justify"><strong>Inherently resistant microorganisms</strong></p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify"><u>Gram-positive aerobes</u>:</p><p style="text-align:justify"><em>Enterococcus faecalis Enterococcus faecium</em></p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify"><u>Gram-negative aerobes:</u></p><p style="text-align:justify"><em>Acinetobacter </em>spp. <em>Campylobacter </em>spp. <em>Morganella morganii Proteus vulgaris Pseudomonas aeruginosa</em></p><p style="text-align:justify"><em>Serratia marcescens</em></p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify"><u>Gram-negative anaerobes:</u></p><p style="text-align:justify"><em>Bacteroides fragilis</em></p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify"><u>Others:</u></p><p style="text-align:justify"><em>Chlamydia </em>spp.</p><p style="text-align:justify"><em>Mycoplasma </em>spp.</p><p style="text-align:justify"><em>Legionella </em>spp.</p></td></tr></tbody></table><p style="text-align:justify">* All methicillin-resistant <em>S. aureus </em>are resistant to cefuroxime.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify"><u>Absorption</u></p><p style="text-align:justify">After oral administration cefuroxime axetil is absorbed from the gastrointestinal tract and rapidly hydrolysed in the intestinal mucosa and blood causing the release of the active compound cefuroxime into the circulation. Optimum absorption occurs when Cefuroxime is taken shortly after a meal (50-60%).</p><p style="text-align:justify">Following administration of cefuroxime axetil tablets peak serum levels (2.1 mcg/ml for a 125 mg dose, 4.1 mcg/ml for a 250 mg dose, 7.0 mcg/ml for a 500 mg dose and 13.6 mcg/ml for a 1000 mg dose) occur approximately 2 to 3 hours after dosing when taken with food. The rate of absorption of cefuroxime from the suspension is reduced compared with the tablets, leading to later, lower peak serum levels and reduced systemic bioavailability (4 to 17% less). Cefuroxime axetil oral suspension was not bioequivalent to cefuroxime axetil tablets when tested in healthy adults and therefore is not substitutable on a milligram-per-milligram basis (see section 4.2).The pharmacokinetics of cefuroxime is linear over the oral dosage range of 125 to 1000 mg. No accumulation of cefuroxime occurred following repeat oral doses of 250 to 500 mg.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><u>Distribution</u></p><p style="text-align:justify">Protein binding has been stated as 33 to 50% depending on the methodology used. Following a single dose of cefuroxime axetil 500 mg tablet to 12 healthy volunteers, the apparent volume of distribution was 50 L (CV%=28%).</p><p style="text-align:justify">Concentrations of cefuroxime in excess of the minimum inhibitory levels for common pathogens can be achieved in the tonsilla, sinus tissues, bronchial mucosa, bone, pleural fluid, joint fluid, synovial fluid, interstitial fluid, bile, sputum and aqueous humor. Cefuroxime passes the blood- brain barrier when the meninges are inflamed.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><u>Biotransformation</u></p><p style="text-align:justify">Cefuroxime is not metabolised.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><u>Elimination</u></p><p style="text-align:justify">The serum half-life is between 1 and 1.5 hours. Cefuroxime is excreted by glomerular filtration and tubular secretion. The renal clearance is in the region of 125 to 148 ml/min/1.73 m<sup>2</sup>.</p><p style="text-align:justify"><strong><em><u>Special patient populations</u></em></strong></p><p style="text-align:justify"><u>Gender</u></p><p style="text-align:justify">No differences in the pharmacokinetics of cefuroxime were observed between males and females.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><u>Elderly</u></p><p style="text-align:justify">No special precaution is necessary in the elderly patients with normal renal function at dosages up to the normal maximum of 1 g per day. Elderly patients are more likely to have decreased renal function; therefore, the dose should be adjusted in accordance with the renal function in the elderly (see section 4.2).</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><u>Paediatrics</u></p><p style="text-align:justify">In older infants (aged &gt;3 months) and in children, the pharmacokinetics of cefuroxime are similar to that observed in adults.</p><p style="text-align:justify">There is no clinical trial data available on the use of cefuroxime axetil in children under the age of 3 months.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><u>Renal impairment</u></p><p style="text-align:justify">The safety and efficacy of cefuroxime axetil in patients with renal failure have not been established. Cefuroxime is primarily excreted by the kidneys. Therefore, as with all such antibiotics, in patients with markedly impaired renal function (i.e. C1cr &lt;30 ml/minute) it is recommended that the dosage of cefuroxime should be reduced to compensate for its slower excretion (see section 4.2). Cefuroxime is effectively removed by dialysis.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><u>Hepatic impairment</u></p><p style="text-align:justify">There are no data available for patients with hepatic impairment. Since cefuroxime is primarily eliminated by the kidney, the presence of hepatic dysfunction is expected to have no effect on the pharmacokinetics of cefuroxime.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><u>Pharmacokinetic/pharmacodynamic relationship</u></p><p style="text-align:justify">For cephalosporins, the most important pharmacokinetic-pharmacodynamic index correlating with <em>in vivo </em>efficacy has been shown to be the percentage of the dosing interval (%T) that the unbound concentration remains above the minimum inhibitory concentration (MIC) of cefuroxime for individual target species (i.e. %T&gt;MIC).</p><p style="text-align:justify">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">Non-clinical data reveal no special hazard for humans based on studies of safety pharmacology, repeated dose toxicity, genotoxicity and toxicity to reproduction and development. No carcinogenicity studies have been performed; however, there is no evidence to suggest carcinogenic potential.</p><p style="text-align:justify">Gamma glutamyl transpeptidase activity in rat urine is inhibited by various cephalosporins, however the level of inhibition is less with cefuroxime. This may have significance in the interference in clinical laboratory tests in humans.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">Excipients are Microcrystalline Cellulose, Pregelatinised Starch, Croscarmellose Sodium, Sodium Lauryl Sulphate, Tabcoat TC (White), Dichloromethane and Isopropyl Alcohol.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                36 Months

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C.</p><p>KEEP OUT OF THE REACH OF CHILDREN</p><p>Protect from light and moisture</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Aluminium / Aluminium foil triple laminate blister packing Pack size: 2 x 5&rsquo;s (10) tablets</p><p>20 x 5&rsquo;s (100) tablets</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                OMAN PHARMACEUTICAL PRODUCTS CO. L.L.C. Plot No 101, Raysut Industrial Estate
Salalah, Sultanate of Oman

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                October 2021
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>